Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004

Annals of Oncology

Volumn 19, Issue 9, 2008, Pages 1600-1604

  Meulenbeld, H J ^a   van Steenbergen, L N ^b   Janssen Heijnen, M L G ^b   Lemmens, V E P P ^b   Creemers, Geert Jan ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

Author keywords

Chemotherapy; Colon cancer; Population based cancer registries; Survival

Indexed keywords

AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER REGISTRY; CANCER SURVIVAL; COLON CANCER; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NETHERLANDS; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR LOCALIZATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; NETHERLANDS; PROBABILITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 50849115766     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn176     Document Type: Article

References (27)

1. IKCnet. Vereniging van Integrale Kankercentra. http://www.ikcnet.nl (April 2008, date last accessed).
2. Jernal Ahmedin, Siegel Rebecca, Ward Elizabeth et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
3. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: A systematic review of published series. Ann Thorac Surg 2007; 84(1): 324-338.
4. Al-Asfoor A, Fedorowicz Z. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database Syst Rev 2007; (3): CD006039.
5. Palliative chemotherapy for advanced or metastatic ccolorectal cancer: Colorectal Meta-analysis Collaboration. Cochrane Database Syst Rev 2000; (2): CD001545-CD001545.
6. Glimelius B, Hoffman K, Graf W et al. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Cancer 1994; 73(3): 556-562.
7. Scheithauer W, Rosen H, Kornek GV et al. Randomised comparison of combination chemotherapy plus supportive care alone in patents with metastatic colorectal cancer. BMJ 1993; 306: 752-755.
8. de Gramont A, Figer A, Seymour M et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947.
9. Douillard JY, Cunningham D, Roth AD et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial. Lancet 2000; 355: 1041-1047.
10. Saltz LB, Cox JV, Blanke C et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000; 343: 905-914.
11. Hurwitz HI, Fehrenbacher L, Hainsworth JD et al. Bevacizumab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer. J Clin Oncol 2005; 23: 3502-3508.
12. Kabbinavar FF, Hambleton J, Mass RD et al. Combined analysis of efficacy: The addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 2005; 23: 3706-3712.
13. Kabbinavar FF, Schulz J, McCleod M et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: Results of a randomized phase II trial. J Clin Oncol 2005; 23: 3697-3705.
14. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
15. Emmanouilides C, Sfakiotaki G, Androulakis N et al. Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: A multicenter phase II study. BMC Cancer 2007; 7: 91.
16. Giuliani F, Colucci G. Cetuximab in colon cancer. Int J Biol Markers 2007; 22: S62-S70.
17. Wong SF. Cetuximab: An epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer. Clin Ther 2005; 27(6): 684-694.
18. Janssen-Heijnen MLG, Louwman WJ, van de Poll-Franse et al. Results of 50 Years Cancer Registry in the South of The Netherlands: 1955-2004. Eindhoven, The Netherlands: Eindhoven Cancer Registry 2005 [in Dutch].
19. Fritz AP, Jack C, Shanmugaratnam A et al. International Classification of Diseases for Oncology, 3rd edition, Geneva: World Health Organisation 2000.
20. UICC. Sobin LH, Wittekind C (eds): TNM Classification of Malignant Tumours, 6th edition. Geneva: Wiley-Liss 2002; 72-76.
21. Schouten LJ, Hoppner P, van den Brandt P et al. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993; 22(3): 369-376.
22. Scheithauer W, Rosen H, Kornek GV et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993; 306: 752-755.
23. Meta-analysis Group in Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 1998; 16: 301-308.
24. Koopman M, Antonini NF, Douma J et al. Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study. Ann Onool 2006; 17(10): 1523-1528.
25. Koopman M, Antonini NF, Douma J et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): A phase III randomised controlled trial. Lancet 2007; 370(9582): 135-142.
26. Jonsson B, Wilking. N. A global comparison regarding patient access to cancer drugs. Ann Oncol 2007; 18 (Suppl 3): 1-77.
27. Lemmens VEPP, van Halteren AH, Janssen-Heijnen MLG et al. Adjuvant treatment for elderly patents with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 2005; 162: 767-772.